Edgen Stock·Sep 29 2025, 12:41戻る
戻る
Cytokinetics Shares Advance Following Positive Aficamten Clinical Data Presentation
Edgen Stock·Sep 29 2025, 12:41
[1] Cytokinetics Presents New Data Related to Aficamten at the HFSA Annual Scientific Meeting 2025 (https://finance.yahoo.com/news/cytokinetics-p ...)[2] Cytokinetics (CYTK) Reveals Promising Aficamten Data at Heart Fa - GuruFocus (https://vertexaisearch.cloud.google.com/groun ...)[3] Cytokinetics stock maintains Buy rating at Stifel on promising aficamten data - Investing.com (https://vertexaisearch.cloud.google.com/groun ...)